首页> 美国卫生研究院文献>Biochemical Journal >Focal adhesion kinase (pp125FAK) cleavage and regulation by calpain.
【2h】

Focal adhesion kinase (pp125FAK) cleavage and regulation by calpain.

机译:钙粘附素对粘着斑激酶(pp125FAK)的切割和调节。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Focal adhesion kinase (125 kDa form; pp125FAK) is a widely expressed non-receptor tyrosine kinase that is implicated in integrin-mediated signal transduction. We have identified a novel means of pp 125FAK regulation in human platelets, in which this kinase undergoes sequential proteolytic modification from the native 125 kDa form to 90, 45 and 40 kDa fragments in thrombin-, collagen- and ionophore -stimulated platelets. The proteolysis of pp125FAK was prevented by pretreating platelets with the calpain inhibitors calpeptin or calpain inhibitor-1, and was reproduced in vitro by incubating immunoprecipitated pp125FAK with purified calpain. Proteolysis of pp125FAK resulted in a dramatic reduction in its autokinase activity and led to its dissociation from the cytoskeletal fraction of platelets. These studies define a novel signal-terminating role for calpain, wherein proteolytic modification of pp125FAK attenuates its autokinase activity and induces its subcellular relocation within the cell.
机译:局灶性粘附激酶(125 kDa形式; pp125FAK)是一种广泛表达的非受体酪氨酸激酶,与整联蛋白介导的信号转导有关。我们已经确定了人类血小板中pp 125FAK调控的新手段,其中该激酶经历了从凝血酶,胶原和离子载体刺激的血小板中的天然125 kDa形式到90、45和40 kDa片段的顺序蛋白水解修饰。用钙蛋白酶抑制剂钙蛋白酶或钙蛋白酶抑制剂-1预处理血小板可防止pp125FAK的蛋白水解,并通过将免疫沉淀的pp125FAK与纯化的钙蛋白酶孵育而在体外复制。 pp125FAK的蛋白水解导致其自身激酶活性急剧降低,并导致其与血小板的细胞骨架部分解离。这些研究定义了钙蛋白酶的新型信号终止作用,其中pp125FAK的蛋白水解修饰减弱了其自身激酶活性,并诱导了其在细胞内的亚细胞定位。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号